ST3GAL6

Chr 3

ST3 beta-galactoside alpha-2,3-sialyltransferase 6

Also known as: SIAT10, ST3GALVI

This enzyme transfers sialic acid residues to terminal galactose on glycoproteins and glycolipids, synthesizing selectin ligands essential for neutrophil recruitment during inflammation and lymphocyte homing to lymph nodes. Biallelic mutations cause autosomal recessive intellectual disability with seizures and dysmorphic features, typically manifesting in infancy or early childhood. The gene shows very low constraint against loss-of-function variants, consistent with recessive inheritance requiring biallelic mutations for disease manifestation.

OMIMResearchSummary from RefSeq, UniProt
LOEUF 1.20
Clinical SummaryST3GAL6
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.20LOEUF
pLI 0.000
Z-score 0.93
OE 0.76 (0.501.20)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.91Z-score
OE missense 0.81 (0.700.93)
141 obs / 174.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.76 (0.501.20)
00.351.4
Missense OE0.81 (0.700.93)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 14 / 18.3Missense obs/exp: 141 / 174.8Syn Z: -0.34

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ST3GAL6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →